After 1 month and 3 months of treatment with TACE or RFA in HCC patients, mean serum levels of AFP, AFP-L3 and PIVKA-II markers decreased compared with before treatment. Conclusions: The combination of three markers AFP, AFP-L3 and PIVKA-II increases the predictive power of imaging response after treatment of HCC patients compared with the use of each marker alone.